Matrix metalloproteinases in cerebral ischemia.
Matrix metalloproteinases (MMPs) are involved in the pathophysiology of several central nervous system diseases that share common pathogeneses, such as disruption of the blood-brain barrier (BBB), neuroinflammation, oxidative stress, and remodeling of the extracellular matrix (ECM). In early ischemic injury, MMPs participate in disruption of the BBB by digesting the basal lamina of capillaries and ECM, leading to vasogenic edema and hemorrhagic transformation. However, ECM degradation and remodeling are essential for tissue recovery, with MMPs having a key role as modulators of homeostasis between neuronal death and tissue regeneration. Thus, MMPs may be a double-edged sword that has a deleterious or beneficial role depending on the stage of brain injury.
Kim
Hahn Young
HY
Department of Neurology, Konkuk University Hospital, Center for Geriatric Neuroscience Research, Institute of Biomedical Science and Technology, Konkuk University, Seoul, Korea.
Han
Seol-Heui
SH
J Neurosci Res. 2002 Jul 1;69(1):1-9
12111810
Ann N Y Acad Sci. 1992 Dec 4;667:1-12
1339240
Neurology. 1998 Sep;51(3 Suppl 3):S3-8
9744823
J Am Coll Cardiol. 2006 Apr 4;47(7):1369-78
16580524
Stroke. 2006 Jun;37(6):1399-406
16690896
J Cereb Blood Flow Metab. 2000 Dec;20(12):1681-9
11129784
Neurosurgery. 2002 Nov;51(5):1128-34; discussion 1134-5
12383357
Neurosurgery. 1997 Sep;41(3):642-66; discussion 646-7
9310982
Stroke. 2000 Dec;31(12):3034-40
11108768
J Clin Invest. 1994 Dec;94(6):2493-503
7989608
Annu Rev Cell Dev Biol. 2001;17:463-516
11687497
Nat Med. 2003 Apr;9(4):371-2; author reply 372-3
12669038
Trends Neurosci. 2000 Jun;23(6):265-71
10838596
Scand J Clin Lab Invest. 2004;64(3):255-61
15222636
Acta Neuropathol. 2000 Feb;99(2):91-5
10672313
Neuroreport. 2001 Sep 17;12(13):3003-7
11588620
Glia. 2002 Sep;39(3):279-91
12203394
Atherosclerosis. 2006 Jul;187(1):161-9
16259988
Ann Vasc Surg. 2005 Jul;19(4):529-33
15981119
Stroke. 2004 Jun;35(6):1316-22
15087562
Nat Med. 2006 Apr;12(4):390-1
16598283
Stroke. 1998 Aug;29(8):1580-3
9707196
Circulation. 2003 Feb 4;107(4):598-603
12566373
Neurosci Lett. 2000 Sep 22;291(3):201-3
10984641
Eur Neurol. 2005;53(3):155-7
15942243
J Intern Med. 2006 May;259(5):530-6
16629857
Stroke. 2001 May;32(5):1162-8
11340226
J Neurol Neurosurg Psychiatry. 1997 Dec;63(6):749-53
9416809
Neurochem Int. 2003 Aug;43(3):191-6
12689599
Biochim Biophys Acta. 2000 Mar 7;1477(1-2):267-83
10708863
Eur J Vasc Endovasc Surg. 2006 Sep;32(3):238-45
16774841
Clin Neuropathol. 2001 Mar-Apr;20(2):60-3
11327298
Intern Med J. 2005 Jun;35(6):331-5
15892761
J Cereb Blood Flow Metab. 2001 Dec;21(12):1393-400
11740200
Stroke. 1997 Jul;28(7):1423-9
9227695
EMBO J. 2002 Dec 16;21(24):6643-8
12485985
Stroke. 2004 Jun;35(6):e159-62
15105518
Circulation. 1995 Sep 15;92(6):1393-8
7664418
J Cereb Blood Flow Metab. 1998 Nov;18(11):1163-72
9809504
Nat Med. 2006 Apr;12(4):441-5
16565723
Stroke. 1997 Mar;28(3):652-9
9056627
Stroke. 2002 Nov;33(11):2711-7
12411666
Neurosci Lett. 1997 Nov 28;238(1-2):53-6
9464653
Proc Natl Acad Sci U S A. 1990 Jul;87(14):5578-82
2164689
J Cereb Blood Flow Metab. 2003 Dec;23(12):1408-19
14663336
Prog Brain Res. 2002;138:451-64
12432784
J Neurol Sci. 2003 Mar 15;207(1-2):71-6
12614934
Circ Res. 2003 May 2;92(8):827-39
12730128
Stroke. 1998 Oct;29(10):2189-95
9756602
Nat Rev Neurosci. 2001 Jul;2(7):502-11
11433375
Stroke. 2002 Mar;33(3):831-6
11872911
Stroke. 2001 Nov;32(11):2472-9
11692003
Eur J Clin Invest. 2005 Sep;35(9):537-45
16128859
Stroke. 2003 Sep;34(9):2165-70
12907822
Atherosclerosis. 2007 Jan;190(1):199-204
16510149
Stroke. 1995 Nov;26(11):2120-6
7482660
Stroke. 2001 Dec 1;32(12):2762-7
11739970
Nat Med. 2001 Jan;7(1):59-64
11135617
AJNR Am J Neuroradiol. 2005 Nov-Dec;26(10):2481-7
16286388
Stroke. 2001 Aug;32(8):1759-66
11486102
J Neurosci. 2001 Oct 1;21(19):7724-32
11567062
Stroke. 2003 Jan;34(1):40-6
12511748
J Cereb Blood Flow Metab. 1999 Jun;19(6):624-33
10366192
Glia. 2005 Jun;50(4):329-39
15846802
J Cereb Blood Flow Metab. 1999 Sep;19(9):1020-8
10478654